Related Experiment Videos
Inherited complement deficiencies in animals
1Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff, UK.
Abstract:
Following the initial description of natural C5 deficiency in inbred mice, a growing number of complement component deficiencies in animals have been described, caused by a variety of genetic defects. Studies on such animals have contributed greatly to an understanding of the specific roles of classical, alternative and terminal pathway activation and inhibition in many infectious and inflammatory diseases. Further investigations in the more recently described models, in combination with the use of genetically engineered knockout mice (with targeted disruption of individual complement components and inhibitors), should continue to provide a fertile source of information regarding the role of complement in such experimental situations. This information is likely to have significant therapeutic implications for human disease.
Insights
Animal models with complement component deficiencies, including genetically engineered mice, are crucial for understanding complement
Area of Science:
- Immunology and Genetics
- Animal Models in Disease Research
Background:
- Natural complement component deficiencies in animals, starting with C5 deficiency in mice, are increasingly documented.
- These deficiencies arise from diverse genetic defects.
- Studies using these animal models have significantly advanced the understanding of complement system pathways.
Purpose of the Study:
- To highlight the importance of animal models with complement deficiencies.
- To emphasize the role of these models in elucidating complement's function in disease.
- To suggest future research directions using advanced genetic models.
Main Methods:
- Description of naturally occurring complement deficiencies in various animal species.
- Utilization of genetically engineered knockout mice with targeted disruptions of complement components and inhibitors.
- Comparative analysis of complement pathway activation and inhibition in disease models.
Main Results:
- Animal studies have elucidated the specific roles of classical, alternative, and terminal complement pathways in infectious and inflammatory diseases.
- Naturally occurring and genetically modified animal models provide insights into complement's complex functions.
- Research highlights the critical involvement of complement in disease pathogenesis.
Conclusions:
- Continued investigation of complement-deficient animal models, especially knockout mice, will yield vital information.
- Understanding complement's role in experimental models has significant potential for therapeutic applications in human diseases.
- Complement research in animal models is essential for developing novel treatments for inflammatory and infectious conditions.